Date:7/7/2009

ibitor II-6 Telaprevir (VX-950) - The Most Promising Pipeline HCV Protease Inhibitor II-6 Boceprevir - Schering's PI Class Lead Candidate II-7 Comparison Between Telaprevir and Boceprevir II-7 Telaprevir and Boceprevir - A Comparison II-8 Polymerase Inhibitors (PLIs) - Adding More Teeth to HCV Pipeline II-8 Viral Polymerases II-8 Polymerase Inhibitor Drugs in Pipeline by Company, Category, and Development Stage II-9 Comparison of Antiviral Properties in Select Polymerase Inhibitor Drugs II-9 R7128 - A Promising PLI Class Drug II-10 Development of PLIs Remains a Challenge for HCV Researchers II-10 Industry in Search of Novel STAT-C Drugs II-10 Specific Antiviral Activity of Select HCV Drug Classes II-10 Select NS5A Inhibitors, Entry Inhibitors, and Thiazolides in Pipeline by Company and Development Stage II-11 Researchers Show Continued Appetite for Immunomodulators and Other Classes II-11 Immunomodulators in Pipeline by Company, and Development Stage II-11 Adjuvant Therapies to Compete with Mainline Therapies II-12 Cyclophilin Analogs and Fibrosis/Inflammation Inhibitors in Pipeline by Company II-12 Vaccine Development Remains at Low Scale II-12 HCV Vaccines in Pipeline by Company, and Development Stage II-12 Decisive Factors For Success of New HCV Therapeutics II-13 HCV Treatment Costs to Escalate II-13 Table 5: HCV Treatment Market: Cost Structure for Years 2007 through 2016 and Beyond (includes corresponding Graph/Chart) II-13 Roche & Schering - Dominant Players in HCV Therapeutics Market II-14 HCV Drugs from Roche & Schering II-14 Partnerships in R&D Become Order of the Day II-14 Select Partnership Deals in HCV Drug Development Programs II-15 Market Drivers/Constraints II-16 Treatment-Experienced Patients - A Potential Opportunity for Developers II-16 Education Campaig
'/>"/>

SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related medicine news :

1. Tyco to Report Third Quarter Results July 30, 2009
2. Death Penalty and Mental Illness: Families of Victims Speak out at National Convention; Double Tragedies Report Released
3. Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported
4. Statement by John Bailey, Chief Scientist The Personal Care Products Council, Response to EWGs 2009 Sunscreen Report
5. BioTrends Announces a New Syndicated Report Series, LaunchTrends(TM): Feraheme
6. New Report Finds Obesity Epidemic Increases, Mississippi Weighs in as Heaviest State
7. Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis, But Worries About Risk of Rationing
8. Recent News Reports of Sweetener Reformulations Raise Questions About Motivations
9. Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015, According to a New Report by Global Industry Analysts
10. Media Alert: Questions Remain in Michael Jackson Autopsy - College of American Pathologists Has Forensic Pathologist Available to Answer Reporter Questions
11. Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care